Myelodysplastic Syndromes
Splenomegaly and myeloproliferative disorders increased risk for porto-spleno-mesenteric venous thrombosis after splenectomy.
Plasma thrombopoietin was significantly higher in aplastic anemia and myelodysplastic syndromes compared with control values.
A study aimed to validate the use of the Molecular International Prognostic Scoring System for myelodysplastic syndromes.
The bone marrow microenvironment of myelodysplastic syndromes is very different from that of acute myeloid leukemia.
Methylation-based sequencing appears to be a viable risk-assessment tool for myelodysplastic syndromes.
Researchers conducted a study to discern clinical predictors for the development of venous thromboembolism (VTE) in ...
The use of machine learning methods is a viable option for identifying patients with myelodysplastic syndrome (MDS), ...
Mutated Stromal Antigen 2 (mSTAG2) coding genes are more common in elderly men and patients with MDS.
In a study presented at the 2022 American Society of Clinical Oncology Annual Meeting, researchers assessed two unique ...
According to a poster at the 2022 American Society of Clinical Oncology, the combination of the anti-CD47 monoclonal ...
Researchers, led by Amber Afzal, evaluated the effect of statins in patients with myelodysplastic syndromes (MDS) after ...
According to Jing Wang and collaborating researchers, the combination of sintilimab and decitabine is relative safe and ...
Advertisement
Expert Interviews on Hematology
Advertisement
